Natixis’s Abbott ABT Stock Holding History

Natixis’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,357	Closed	-$146K	–	1071
2022 Q2	$146K	Buy	+1,357	New	+$154K	﹤0.01%	1045

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Natixis's ABT Position: Q2 2026 in Review

Natixis reduced its Abbott (ABT) stake by 76% in Q2 2026, selling an estimated $54.1M and leaving 185,746 shares worth $16.9M. The position accounts for 0.07% of the portfolio, ranked #199.

Natixis first reported a position in ABT in Q2 2013 and has held it in 40 quarters since. The position peaked at $100M in Q1 2022. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Natixis held 185,746 shares of Abbott worth $16.9M as of Q2 2026.
Natixis sold 593,157 Abbott shares in Q2 2026, an estimated $54.1M.
Abbott made up 0.07% of Natixis's portfolio in Q2 2026, its #199 holding.
Natixis first reported a position in Abbott in Q2 2013 and has held it in 40 quarters since.
Natixis's Abbott position peaked at $100M in Q1 2022.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.